SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bosco who wrote (734)3/3/2000 8:16:00 AM
From: david james   of 1298
 
Bosco,
I quite agree. They should and will certainly be putting that money to work. My guess is that acquire a couple companies with good pipelines that are needing the sort of cash that CEGE has available.

But what is impressive is that even before this cash inflow, the company is already near to break even. It is going to take a while to burn through that $250 mill in cash, and the $700 mill in ABGX stock is on hand if they are still feeling hungry.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News